Efficacy of Tianeptine in Anxious-Depressed Patients: Results of a Controlled Multicenter Trial versus Amitriptyline
The DOI matches its Crossref record.
Abstract
265 adult outpatients with dysthymic disorder (DSM-III) associated with clinically manifest anxiety (according to FDA criteria) were included in a multicenter, randomized double-blind study. The trial consisted of three phases: placebo pretreatment phase and inclusion in the trial, treatment phase, placebo posttreatment phase. Patients were treated in mono therapy for 42 days with a mean dosage of 3 tablets per day corresponding to 37.5 mg/day of tianeptine or 75 mg/day of amitriptyline respectively. The following assessment instruments were used: the Montgomery and Åsberg Depression Rating Scale (MADRS), the Hamilton Anxiety Rating Scale (HARS), and the Check-List for the Evaluation of Somatic Symptoms of J.D. Guelfi and C.B. Pull (CHESS 82). Analysis of MADRS total scores showed an important and rapid improvement in tianeptine and amitriptyline groups, reaching statistical significance as soon as D7. At the end of the 6-week treatment period the tianeptine group reached a decrease of 64% in the initial MADRS total score versus 69% in the amitriptyline group. 78% of patients treated with tianeptine and 83% of patients treated with amitriptyline were considered as treatment responders. There was no difference in drop-out rates between the two groups. HARS scores showed a decrease in psychic as well as somatic anxiety in both groups. The action of tianeptine on anxious-depressive symptomatology was confirmed by the concomitant improvement of global clinical rating and patients’ self-rating (HSCL). Statistical comparison of all clinical rating-scale scores in patients having completed the trial failed to show any significant group differences. The antidepressant and anxiolytic activities of tianeptine could be considered as not different from those of amitriptyline during the trial period of 6 weeks. Clinical safety of both treatments was satisfactory. Tianeptine had less anticholinergic side effects and was less sedative than amitriptyline, resulting in a lower frequency of signs of drowsiness and retardation reported in the former group. No signs of rebound, symptom recrudescence and physical and/or psychological dependence were reported in both groups after discontinuation of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Conrad, C. D., Galea, L. A. M., Kuroda, Y., & McEwen, B. S. (1996) · Behavioral Neuroscience · doi:10.1037/0735-7044.110.6.1321 · Cited by 784
McEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406
Tianeptine: A Review of its Use in Depressive Disorders
Wagstaff, A. J., Ormrod, D., & Spencer, C. M. (2001) · CNS Drugs · doi:10.2165/00023210-200115030-00006 · Cited by 394
Neurobiological and clinical effects of the antidepressant tianeptine
Kasper, S., & McEwen, B. S. (2008) · CNS Drugs · doi:10.2165/00023210-200822010-00002 · Cited by 302
“2 Tolerability tianeptine was generally equivalent to amitriptyline (n = 107–284),[73-75] imipramine (n = 186),[76] mianTianeptine is generally well tolerated.”
Guaiana, G., Barbui, C., & Hotopf, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004186.pub2 · Cited by 271
Metadata
- Authors
- Guelfi, J. D., Pichot, P., & Dreyfus, J. F.
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 1989
- Volume
- 22
- Issue
- 1
- Pages
- 41-48
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W1973048808
- Cited by
- 80
- References
- 0
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Tianeptine in Anxious-Depressed Patients: Results of a Controlled Multicenter Trial versus Amitriptyline. https://app.cochat.ai/papers/10.1159/000118590
- The paper
- Guelfi, J. D., Pichot, P., & Dreyfus, J. F. (1989). Efficacy of Tianeptine in Anxious-Depressed Patients: Results of a Controlled Multicenter Trial versus Amitriptyline. Neuropsychobiology. https://doi.org/10.1159/000118590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.